News

Prasco plans to start shipping Nitrofurantoin Oral Suspension immediately in the US under the Prasco label. Nitrofurantoin is used to treat urinary tract infections. Prasco CEO Thomas Arington

Squalamine is a small molecule anti-angiogenic which is used in the treatment of wet-age related macular degeneration (AMD) and Oncology. Ohr Pharmaceutical CEO Irach Taraporewala said all previous

The trial will evaluate Sym004 in patients suffering from recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN). The Phase 2 trial aims at progression

PRA is a provider of personalized service customized to the requirements of each study. The company is conducting trials in Romania since 2006. PRA Clinical Operations in Europe,

Centricity Business 5.0 improves ability to meet risks of growing self-pay patient population by reducing human touch across the patient access and revenue cycle processes. The application provides

The lawsuit alleges that the companies failed to warn the consumers of Actos regarding the increased risk of bladder cancer associated with pioglitazone, sold under the brand name

The tie up allows Rechon to manufacture and market Zolpimist, an oral spray formulation of zolpidem tartrate, outside North America. As per the terms of the agreement, NovaDel

The drug is used for the reduction of rate of thrombotic cardiovascular (CV) events in patients suffering from acute coronary syndrome (ACS). Brilinta has demonstrated reduction in the

The drug has been approved for use in conjunction with two different hepatitis C drugs, pegylated-interferon and ribavirin. The combined dosage is indicated for the patients who are